Neo Ivy Capital Management Tandem Diabetes Care Inc Transaction History

Neo Ivy Capital Management

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$53.22 - $123.09 $120,064 - $277,691	-2,256 Reduced 98.95%	24 $1,000
Q1 2022 May 16, 2022	BUY	$101.89 - $150.09 $172,295 - $253,802	1,691 Added 287.1%	2,280 $266,000
Q4 2021 Feb 15, 2022	BUY	$118.18 - $153.21 $52,826 - $68,484	447 Added 314.79%	589 $88,000
Q3 2021 Nov 16, 2021	BUY	$93.51 - $129.4 $13,278 - $18,374	142 New	142 $14,000
Q2 2021 Aug 16, 2021	SELL	$77.0 - $100.19 $45,815 - $59,613	-595 Closed	0 $0
Q1 2021 Oct 07, 2021	BUY	$81.28 - $104.34 $48,361 - $62,082	595 New	595 $53,000
Q2 2020 Aug 17, 2020	SELL	$60.05 - $98.92 $8,527 - $14,046	-142 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$60.05 - $98.92 $8,527 - $14,046	142 New	142 $14,000
Q4 2019 Feb 13, 2020	SELL	$53.13 - $71.19 $273,778 - $366,842	-5,153 Closed	0 $0
Q3 2019 Nov 21, 2019	BUY	$57.11 - $73.3 $294,287 - $377,714	5,153 New	5,153 $373,000
Q2 2019 Aug 15, 2019	SELL	$54.41 - $71.7 $133,957 - $176,525	-2,462 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$32.25 - $73.56 $79,399 - $181,104	2,462 New	2,462 $156,000

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.97B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.